ArticlePharmaceuticals (Basel, Switzerland)2024

Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction.

Sara M Villada-Troncoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.